Global Personalized Medicine Market Valuation and Growth Prospects: $650.59 Billion by 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the personalized medicine market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Personalized Medicine Market Size?

The personalized medicine market has experienced significant expansion in recent years. This market is expected to expand from $386.27 billion in 2024 to $422.9 billion by 2025, reflecting a compound annual growth rate (CAGR) of 9.5%. Historically, the market’s growth was fueled by the emergence of companion diagnostics, a focus on patient-centric healthcare, evolving drug development approaches, measures for healthcare cost containment, and the growing incidence of chronic diseases.

The personalized medicine market is anticipated to experience substantial expansion in the coming years. It is projected to reach $650.59 billion by 2029, achieving a compound annual growth rate (CAGR) of 11.4%. This growth during the forecast period is primarily driven by sustained genomic advancements, the broadening scope of biomarker discovery, increasing adoption of telemedicine, supportive regulatory frameworks, and enhanced collaboration and data sharing. Noteworthy trends expected over the forecast period include the integration of artificial intelligence (AI), continued advancements in genomic sequencing, sophisticated data integration and analytics, the proliferation of immunotherapy and targeted therapies, greater patient empowerment and informed decision-making, and strategic collaborations and partnerships.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10272&type=smp

What Core Market Drivers Are Expanding The Personalized Medicine Industry?

The increasing occurrence of rare diseases is projected to propel the expansion of the personalized medicine market. This trend reflects the growing count of individuals identified with conditions such as Klinefelter Syndrome, Aarskog Syndrome, and Abetalipoproteinemia. Personalized medicine provides customized therapeutic approaches, catering to the specific requirements of those with rare diseases. As an illustration, in February 2024, data from the Genetic Alliance UK, a UK-based national charity supporting people affected by genetic, rare and undiagnosed conditions, revealed that in the UK, 3.5 million people are living with a rare condition, and 1 in 17 individuals will be affected by a rare condition at some point in their lifetime. Consequently, the ongoing increase in rare disease prevalence is fostering the development of the personalized medicine market.

What Segment Insights Are Highlighted In The Personalized Medicine Market Report?

The personalized medicine market covered in this report is segmented –

1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness

2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications

3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users

Subsegments:

1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging

2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products

3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring

4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs

Which Notable Trends Are Transforming The Personalized Medicine Market Outlook?

Technological innovations constitute a pivotal and increasingly popular trend within the personalized medicine market. Prominent companies in this sector are embracing new technologies to uphold their market presence. For example, in April 2023, OM1, a US-based healthcare firm that employs real-world data and artificial intelligence (AI) to aid healthcare providers, patented an AI-driven platform aimed at accelerating personalized medicine. This system utilizes extensive data analysis to produce valuable insights regarding diagnoses, disease progression, and treatment effectiveness. Its value is rooted in delivering customized healthcare information, bolstering informed decision-making for medical professionals, and speeding up clinical trials by efficiently identifying suitable candidates, thereby fostering the progression of personalized medicine in the market.

Which Firms Are Driving Innovation Within The Personalized Medicine Market?

Major companies operating in the personalized medicine market include Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

What Regional Trends Are Shaping Growth In The Personalized Medicine Market?

North America was the largest region in the personalized medicine market in 2024. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=10272&type=smp

Browse Through More Reports Similar to the Global Personalized Medicine Market 2025, By The Business Research Company

Paints And Coatings Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/paints-and-coatings-global-market-report

Surface Active Agents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/surface-active-agents-global-market-report

Synthetic Pigments Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/synthetic-pigments-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795